Tweet
<img alt="" height="1" width="1" />
GSK melanoma drug combination wins accelerated US approval
Reuters
LONDON (Reuters) - A combination treatment from GlaxoSmithKline for melanoma, the deadliest form of skin cancer, has won accelerated approval from U.S. regulators. The green light for the combined use of Tafinlar, also known as dabrafenib, and Mekinist, ...
GSK gains accelerated FDA approval for combination use of Mekinist ...MarketWatch
GSK Obtains Accelerated FDA Nod For Combination Use Of Mekinist And TafinlarRTT News
GSK receives FDA approval for combination of Mekinist with Tafinlar for ...News-Medical.net
Wall Street Journal
all 14 news articles »
More...